New Nevada law mandates fertility preservation coverage for cancer patients
April 24, 2025 | House Bills - Introduced, House Bills, 2025 House and Senate Bills, Nevada Legislation Bills, Nevada
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
On April 24, 2025, the Nevada State Legislature introduced Assembly Bill 428, a significant piece of legislation aimed at enhancing health insurance coverage for individuals facing fertility risks due to cancer treatments. This bill seeks to address a critical gap in health insurance policies by mandating that group health insurance plans include coverage for fertility preservation procedures for patients diagnosed with breast or ovarian cancer.
The primary provisions of AB 428 require insurers to cover medically necessary fertility preservation services when a healthcare provider determines that cancer treatment may lead to infertility. This includes adherence to established medical practices and guidelines from reputable organizations such as the American Society for Reproductive Medicine and the American Society of Clinical Oncology. The bill also stipulates that any health insurance policy issued or renewed after January 1, 2026, must comply with these requirements, rendering conflicting provisions void.
The introduction of AB 428 has sparked notable discussions among lawmakers, healthcare professionals, and advocacy groups. Proponents argue that the bill is a crucial step toward ensuring that cancer patients have access to comprehensive care that considers their long-term reproductive health. They emphasize the emotional and financial burdens faced by individuals who must navigate fertility preservation amidst cancer treatment, often without adequate insurance support.
Opposition to the bill has emerged from some insurance industry representatives, who express concerns about the potential increase in costs associated with mandated coverage. They argue that such requirements could lead to higher premiums for all policyholders. However, supporters counter that the long-term benefits of preserving fertility for cancer survivors outweigh the initial costs, potentially reducing future healthcare expenses related to infertility treatments.
The implications of AB 428 extend beyond individual health outcomes; they touch on broader social and economic issues. By ensuring that fertility preservation is covered, the bill acknowledges the importance of reproductive health in the context of cancer treatment, promoting a more holistic approach to patient care. Experts suggest that this legislation could set a precedent for similar measures in other states, potentially influencing national health insurance policies.
As the legislative process unfolds, stakeholders will be closely monitoring the bill's progress and any amendments that may arise. The outcome of AB 428 could significantly impact the lives of many Nevadans facing cancer, shaping the landscape of health insurance coverage in the state and beyond.
The primary provisions of AB 428 require insurers to cover medically necessary fertility preservation services when a healthcare provider determines that cancer treatment may lead to infertility. This includes adherence to established medical practices and guidelines from reputable organizations such as the American Society for Reproductive Medicine and the American Society of Clinical Oncology. The bill also stipulates that any health insurance policy issued or renewed after January 1, 2026, must comply with these requirements, rendering conflicting provisions void.
The introduction of AB 428 has sparked notable discussions among lawmakers, healthcare professionals, and advocacy groups. Proponents argue that the bill is a crucial step toward ensuring that cancer patients have access to comprehensive care that considers their long-term reproductive health. They emphasize the emotional and financial burdens faced by individuals who must navigate fertility preservation amidst cancer treatment, often without adequate insurance support.
Opposition to the bill has emerged from some insurance industry representatives, who express concerns about the potential increase in costs associated with mandated coverage. They argue that such requirements could lead to higher premiums for all policyholders. However, supporters counter that the long-term benefits of preserving fertility for cancer survivors outweigh the initial costs, potentially reducing future healthcare expenses related to infertility treatments.
The implications of AB 428 extend beyond individual health outcomes; they touch on broader social and economic issues. By ensuring that fertility preservation is covered, the bill acknowledges the importance of reproductive health in the context of cancer treatment, promoting a more holistic approach to patient care. Experts suggest that this legislation could set a precedent for similar measures in other states, potentially influencing national health insurance policies.
As the legislative process unfolds, stakeholders will be closely monitoring the bill's progress and any amendments that may arise. The outcome of AB 428 could significantly impact the lives of many Nevadans facing cancer, shaping the landscape of health insurance coverage in the state and beyond.
View Bill
This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution
View Bill